REFERENCES
- Quillen D A. Common causes of vision loss in elderly patients. Am Fam Physician. 1999; 60: 99–108
- Klein R, Klein B E, Jensen S C, Mares-Perlman J A, Cruickshanks K J, Palta M. Age-related maculopathy in a multiracial United States population: The National Health and Nutrition Examination Survey III. Ophthalmology. 1999; 106: 1056–1065
- Congdon N, O'Colmain B, Klaver C C, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122: 477–485
- Munoz B, West S K. Blindness and visual impairment in the Americas and the Caribbean. Br J Ophthalmol. 2002; 86: 498–504
- The Age-Related Eye Disease Study (AREDS): Design implications. Control Clin Trials 1999; 20: 573–600, AREDS report no. 1
- A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119: 1417–1436
- Mares-Perlman J, Klein R. Diet and Age-related Macular Degeneration. Nutritional and Environmental Influences on the Eye, A Taylor. CRC Press LLC, Boca Raton, FL 1999; 181–214
- Klein R, Klein B E, Linton K L. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992; 99: 933–943
- Wald G. Human vision and the spectrum. Science. 1945; 101: 653–658
- Landrum J T, Bone R A. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys. 2001; 385: 28–40
- Krinsky N I. Possible biologic mechanisms for a protective role of xanthophylls. J Nutr 2002; 132: 540S–542S
- Alves-Rodrigues A, Shao A. The science behind lutein. Toxicol Lett. 2004; 150: 57–83
- Schlach W. The carotenoids of the human retina. Nutritional and Environmental Influences on the Eye, A Taylor. CRC, Boca Raton, FL 1999; 215–250
- Grahn B H, Paterson P G, Gottschall-Pass K T, Zhang Z. Zinc and the eye. J Am Coll Nutr. 2001; 20: 106–118
- Newsome D A, Swartz M, Leone N C, Elston R C, Miller E. Oral zinc in macular degeneration. Arch Ophthalmol. 1988; 106: 192–198
- Gale C R, Hall N F, Phillips D I, Martyn C N. Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2003; 44: 2461–2465
- Mares-Perlman J A, Brady W E, Klein R, et al. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol. 1995; 113: 1518–1523
- Seddon J M, Ajani U A, Sperduto R D, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994; 272: 1413–1420
- VandenLangenberg G M, Mares-Perlman J A, Klein R, Klein B E, Brady W E, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 1998; 148: 204–214
- Flood V, Smith W, Wang J J, Manzi F, Webb K, Mitchell P. Dietary antioxidant intake and incidence of early age-related maculopathy: The Blue Mountains Eye Study. Ophthalmology 2002; 109: 2272–2278
- Smith W, Mitchell P, Webb K, Leeder S R. Dietary antioxidants and age-related maculopathy: The Blue Mountains Eye Study. Ophthalmology. 1999; 106: 761–767
- Cho E, Seddon J M, Rosner B, Willett W C, Hankinson S E. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol. 2004; 122: 883–892
- Cho E, Stampfer M J, Seddon J M, et al. Prospective study of zinc intake and the risk of age-related macular degeneration. Ann Epidemiol. 2001; 11: 328–336
- Mares-Perlman J A, Fisher A I, Klein R, et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third National Health and Nutrition Examination Survey. Am J Epidemiol. 2001; 153: 424–432
- Mares-Perlman J A, Klein R, Klein B E, et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 1996; 114: 991–997
- Abdelsalam A, Del Priore L, Zarbin M A. Drusen in age-related macular degeneration: Pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol 1999; 44: 1–29
- Jacques P F, Chylack L T, Jr., Hankinson S E, et al. Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol. 2001; 119: 1009–1019
- Willett W C. Nutritional Epidemiology. Oxford University Press, New York 1998
- Osganian S K, Stampfer M J, Rimm E, Spiegelman D, Manson J E, Willett W C. Dietary carotenoids and risk of coronary artery disease in women. Am J Clin Nutr 2003; 77: 1390–1399
- Willett W C. Nutritional Epidemiology. Oxford University Press, New York 1998
- Klein R, Davis M D, Magli Y L, Segal P, Klein B E, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991; 98: 1128–1134
- Klein R, Peto T, Bird A, Vannewkirk M R. The epidemiology of age-related macular degeneration. Am J Ophthalmol. 2004; 137: 486–495
- Goldberg J, Flowerdew G, Smith E, Brody J A, Tso M O. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 1988; 128: 700–710
- Delcourt C, Cristol J P, Tessier F, Leger C L, Descomps B, Papoz L. Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liees a l'Age. Arch Ophthalmol. 1999; 117: 1384–1390
- Klein R, Klein B E, Tomany S C, Meuer S M, Huang G H. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 2002; 109: 1767–1779
- Delamere N A. Ascorbic acid and the eye. Subcell Biochem. 1996; 25: 313–329
- Johnson E J, Hammond B R, Yeum K J, et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr 2000; 71: 1555–1562
- Bone R A, Landrum J T, Dixon Z, Chen Y, Llerena C M. Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Exp Eye Res 2000; 71: 239–245
- Berendschot T T, Goldbohm R A, Klopping W A, van de Kraats J, van Norel J, van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 2000; 41: 3322–3326
- Bone R A, Landrum J T, Mayne S T, Gomez C M, Tibor S E, Twaroska E E. Macular pigment in donor eyes with and without AMD: A case-control study. Invest Ophthalmol Vis Sci. 2001; 42: 235–240
- Bernstein P S, Zhao D Y, Wintch S W, Ermakov I V, McClane R W, Gellermann W. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 2002; 109: 1780–1787
- Beatty S, Murray I J, Henson D B, Carden D, Koh H, Boulton M E. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci. 2001; 42: 439–446